These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24378268)

  • 1. Primary prophylaxis with ciprofloxacin in cirrhotic patients with ascites: a randomized, double blind study.
    Téllez-Ávila F; Sifuentes-Osornio J; Barbero-Becerra V; Franco-Guzmán A; Ruiz-Cordero R; Alfaro-Lara R; Hernández-Ramírez A; Vargas-Vorácková F
    Ann Hepatol; 2013 Jan-2014 Feb; 13(1):65-74. PubMed ID: 24378268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial.
    Yim HJ; Suh SJ; Jung YK; Yim SY; Seo YS; Lee YR; Park SY; Jang JY; Kim YS; Kim HS; Kim BI; Um SH
    Am J Gastroenterol; 2018 Aug; 113(8):1167-1176. PubMed ID: 29946179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: a double-blind placebo-controlled randomized-controlled trial.
    Pande C; Kumar A; Sarin SK
    Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):831-9. PubMed ID: 22522141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhotic patients with ascites, without gastro-intestinal bleeding.
    Cohen MJ; Sahar T; Benenson S; Elinav E; Brezis M; Soares-Weiser K
    Cochrane Database Syst Rev; 2009 Apr; (2):CD004791. PubMed ID: 19370611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial.
    Rolachon A; Cordier L; Bacq Y; Nousbaum JB; Franza A; Paris JC; Fratte S; Bohn B; Kitmacher P; Stahl JP
    Hepatology; 1995 Oct; 22(4 Pt 1):1171-4. PubMed ID: 7557868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bacterial infections in liver cirrhosis].
    Papp M; Farkas A; Udvardy M; Tornai I
    Orv Hetil; 2007 Mar; 148(9):387-95. PubMed ID: 17344166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial.
    Grangé JD; Roulot D; Pelletier G; Pariente EA; Denis J; Ink O; Blanc P; Richardet JP; Vinel JP; Delisle F; Fischer D; Flahault A; Amiot X
    J Hepatol; 1998 Sep; 29(3):430-6. PubMed ID: 9764990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
    Novella M; Solà R; Soriano G; Andreu M; Gana J; Ortiz J; Coll S; Sàbat M; Vila MC; Guarner C; Vilardell F
    Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study.
    Terg R; Fassio E; Guevara M; Cartier M; Longo C; Lucero R; Landeira C; Romero G; Dominguez N; Muñoz A; Levi D; Miguez C; Abecasis R
    J Hepatol; 2008 May; 48(5):774-9. PubMed ID: 18316137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ciprofloxacin vs cefazolin in the prevention of infection in cirrhotic patients with gastrointestinal bleeding].
    Díaz Ferrer J; Román R; Bustíos C; Davalos M; Zumaeta E
    Rev Gastroenterol Peru; 2011; 31(4):319-23. PubMed ID: 22476119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low ascitic fluid total protein levels is not associated to the development of spontaneous bacterial peritonitis in a cohort of 274 patients with cirrhosis.
    Mo S; Bendtsen F; Wiese SS; Kimer N
    Scand J Gastroenterol; 2018 Feb; 53(2):200-205. PubMed ID: 29214880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with ascites: a meta-analysis.
    Bernard B; Grangé JD; Khac EN; Amiot X; Opolon P; Poynard T
    Digestion; 1998 Jul; 59 Suppl 2():54-7. PubMed ID: 9718422
    [No Abstract]   [Full Text] [Related]  

  • 13. The efficacy and the immunomodulatory effect of rifaximin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic Egyptian patients.
    Mostafa T; Badra G; Abdallah M
    Turk J Gastroenterol; 2015 Mar; 26(2):163-9. PubMed ID: 25835116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary prophylaxis of spontaneous bacterial peritonitis].
    Soriano G; Guarner C
    Gastroenterol Hepatol; 1997; 20(6):312-4. PubMed ID: 9296848
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.
    Elfert A; Abo Ali L; Soliman S; Ibrahim S; Abd-Elsalam S
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1450-1454. PubMed ID: 27512927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial.
    Singh N; Gayowski T; Yu VL; Wagener MM
    Ann Intern Med; 1995 Apr; 122(8):595-8. PubMed ID: 7887554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis.
    Moreau R; Elkrief L; Bureau C; Perarnau JM; Thévenot T; Saliba F; Louvet A; Nahon P; Lannes A; Anty R; Hillaire S; Pasquet B; Ozenne V; Rudler M; Ollivier-Hourmand I; Robic MA; d'Alteroche L; Di Martino V; Ripault MP; Pauwels A; Grangé JD; Carbonell N; Bronowicki JP; Payancé A; Rautou PE; Valla D; Gault N; Lebrec D;
    Gastroenterology; 2018 Dec; 155(6):1816-1827.e9. PubMed ID: 30144431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prophylaxis of spontaneous bacterial peritonitis in patients with cirrhosis.
    Frazee LA; Marinos AE; Rybarczyk AM; Fulton SA
    Ann Pharmacother; 2005 May; 39(5):908-12. PubMed ID: 15769829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous bacterial peritonitis in cirrhotic patients: Is prophylactic propranolol therapy beneficial?
    Cholongitas E; Papatheodoridis GV; Manesis EK; Burroughs AK; Archimandritis AJ
    J Gastroenterol Hepatol; 2006 Mar; 21(3):581-7. PubMed ID: 16638103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
    Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
    Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.